Hospitals have adopted a take-no-prisoners approach in the fight with Big Pharma over the 340B drug discount program. Can this strategy hold as Congress, oversight agencies, the courts and the Trump administration ratchet up scrutiny of the program?
Armed with comprehensive data, insurers are ramping up their efforts to control costs through population health management.
Physicians are beginning to question how fair the match program is and whether it meets the needs of doctors-in-training and patients.
Heavy hitters Anthem, HCA and UHS will release their Q2 earnings. Meanwhile, a House panel will delve into the MIPS program.
Physician compensation rose only slightly for most medical specialties in 2017 indicating the steady growth in pay seen over the past several years may have started to slow.
The major healthcare innovation story is occurring across the country in cities and small towns, where local hospitals and health systems are now centers of transformational change.
HHS received over 3,000 comments on the Trump administration's Blueprint to Lower Drug Prices, which was released in May. Hospitals, health insurers and drugmakers had plenty to say on how to address soaring drug prices
The healthcare industry has largely been unable to meet consumers' expectations, but a group of health system and physician group executives shared how they plan to change that at Modern Healthcare's Consumerism Symposium.
Growing pay inequality is a huge problem in healthcare. It's going to take a conscious commitment by healthcare's top leaders, sustained over many years, to turn the industry's critical support jobs into good jobs.
Researchers at the University of Texas at Austin built a device using a smartphone and a box made of Legos that can detect nerve gas.